-
1Academic Journal
Συγγραφείς: M. A. Kustova, A. P. Tolmachev, N. A. Shamalov, М. А. Кустова, А. П. Толмачев, Н. А. Шамалов
Πηγή: Neurology, Neuropsychiatry, Psychosomatics; Vol 8, No 2 (2016); 80-86 ; Неврология, нейропсихиатрия, психосоматика; Vol 8, No 2 (2016); 80-86 ; 2310-1342 ; 2074-2711 ; 10.14412/2074-2711-2016-2
Θεματικοί όροι: исследование CARS, rehabilitation, neuroprotectors, cerebrolysin, CARS study, реабилитация, нейропротекторы, церебролизин
Περιγραφή αρχείου: application/pdf
Relation: https://nnp.ima-press.net/nnp/article/view/613/563; Murray CJ, Lopez AD. Measuring the global burden of disease. N Engl J Med. 2013 Aug 1;369(5):448-57. doi:10.1056/NEJMra1201534.; Powers WJ, Derdeyn CP, Biller J, et al., on behalf of the American Heart Association Stroke Council. 2015 AHA/ASA Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment. A Guideline for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke. 2015; 46:3020-3035. Stroke. 2015;46:3020-3035 Published online before print June 29, 2015, doi:10.1161/ STR.0000000000000074; Saver JL, Smith EE, Fonarow GC, et al. GWTG- Stroke Steering Committee and Investigators. The «golden hour» and acute brain ischemia: presenting features and lytic therapy in >30,000 patients arriving within 60 minutes of stroke onset. Stroke. 2010 Jul;41(7):1431-9. doi:10.1161/ STROKEAHA.110.583815. Epub 2010 Jun 3.; Zahuranec DB, Majersik JJ. Percentage of acute stroke patients eligible for endovascular treatment. Neurology. 2012 Sep 25;79(13 Suppl 1):S22-5.; Шамалов НА. Проблемы и перспективы реперфузионной терапии при ишемическом инсульте в России. Фарматека. 2015;302(9):14-9. [Shamalov NA. Problems and prospects of reperfusion therapy in ischemic stroke in Russia. Farmateka. 2015;302(9):14-9. (In Russ.)].; O’Collins VE, Macleod MR, Donnan GA, et al. 1,026 experimental treatments in acute stroke. Ann Neurol. 2006 Mar;59(3):467-77. doi:10.1002/ana.20741; Kaur H, Prakash A, Medhi B. Drug therapy in stroke: from preclinical to clinical studies. Pharmacology. 2013;92(5-6):324-34. doi:10.1159/000356320. Epub 2013 Dec 12.; Xu SY, Pan SY. The failure of animal models of neuroprotection in acute ischemic stroke to translate to clinical efficacy. Med Sci Monit Basic Res. 2013 Jan 28;19:37-45.; Tymianski M. Novel approaches to neuroprotection trials in acute ischemic stroke. Stroke. 2013 Oct;44(10):2942-50. doi:10.1161/ STROKEAHA.113.000731. Epub 2013 Sep 10.; Hossmann KA. The two pathophysiologies of focal brain ischemia: implications for translational stroke research. J Cereb Blood Flow Metab. 2012 Jul;32(7):1310-6. doi:10.1038/jcbfm.2011.186. Epub 2012 Jan 11.; Masliah E, Diez-Tejedor E. The pharmacology of neurotrophic treatment with Cerebrolysin: brain protection and repair to counteract pathologies of acute and chronic neurological disorders. Drugs Today (Barc). 2012 Apr;48 Suppl A:3-24. doi:10.1358/ dot.2012.48(Suppl.A).1739716.; Hartbauer M, Hutter-Paier B, Skofitsch G, Windisch M. Antiapoptotic effects of the peptidergic drug cerebrolysin on primary cultures of embryonic chick cortical neurons. J Neural Transm (Vienna). 2001;108(4):459-73.; Zhang L, Chopp M, Meier DH, et al. Sonic hedgehog signaling pathway mediates cerebrolysin-improved neurological function after stroke. Stroke. 2013 Jul;44(7):1965-72. doi:10.1161/STROKEAHA.111.000831. Epub 2013 May 21.; Gutmann B, Hutter-Paier B, Skofitsch G, et al. In vitro models of brain ischemia: the peptidergic drug cerebrolysin protects cultured chick cortical neurons from cell death. Neurotox Res. 2002 Feb;4(1):59-65. doi:10.1080/ 10298420290007637.; Darsalia V, Heldmann U, Lindvall O, Kokaia Z. Stroke-induced neurogenesis in aged brain. Stroke. 2005 Aug;36(8):1790-5. Epub 2005 Jul 7. doi:10.1161/01. STR.0000173151.36031.be.; Скворцова ВИ, Стаховская ЛВ, Губский ЛВ и др. Рандомизированное двойное слепое плацебоконтролируемое иссле- дование безопасности и эффективности церебролизина для лечения острого ишемиче- ского инсульта. Журнал неврологии и психиатрии им. С.С. Корсакова (Прил. Инсульт). 2004;(S11):51-5. [Skvortsova VI, Stakhovskaya LV, Gubskii LV, et al. A randomized, double-blind, placebocontrolled trial of safety and efficacy of Cerebrolysin for treating acute ischaemic stroke. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova (Suppl. Stroke). 2004;(S11):51-5. (In Russ.)].; Ladurner G, Kalvach P, Moessler H; Cerebrolysin Study Group. Neuroprotective treatment with cerebrolysin in patients with acute stroke: a randomised controlled trial. J Neural Transm (Vienna). 2005 Mar;112(3):415-28. Epub 2004 Dec 7. doi:10.1007/s00702-004-0248-2.; Ziganshina LE, Abakumova T, Kuchaeva A. Cerebrolysin for acute ischaemic stroke. Cochrane Database Syst Rev. 2010 Apr 14;(4): CD007026. doi:10.1002/14651858. CD007026.pub2.; Lang W, Stadler CH, Poljakovic Z, Fleet D; Lyse Study Group. A prospective, randomized, placebo-controlled, double-blind trial about safety and efficacy of combined treatment with alteplase (rt-PA) and Cerebrolysin in acute ischaemic hemispheric stroke. Int J Stroke. 2013 Feb;8(2):95-104. doi:10.1111/j.1747- 4949.2012.00901.x. Epub 2012 Sep 26.; Heiss WD, Brainin M, Bornstein NM, et al; Cerebrolysin Acute Stroke Treatment in Asia (CASTA) Investigators. Cerebrolysin in patients with acute ischemic stroke in Asia: results of a double-blind, placebo-controlled randomized trial. Stroke. 2012 Mar;43(3):630-6. doi:10.1161/STROKEAHA.111.628537. Epub 2012 Jan 26.; Muresanu DF, Heiss WD, Hoemberg V, et al. Cerebrolysin and Recovery After Stroke (CARS). A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial. Stroke. 2016 Jan;47(1):151-9. doi:10.1161/STROKEAHA.115.009416. Epub 2015 Nov 12.; Lyle RC. A performance test for assessment of upper limb function in physical rehabilitation treatment and research. Int J Rehabil Res. 1981;4(4):483-92. doi:10.1097/ 00004356-198112000-00001.; Posteraro L, Formis A, Grassi E, et al. Quality of life and aphasia. Multicentric standardization of a questionnaire. Eura Medicophys. 2006 Sep;42(3):227-30.; Goodglass H, Kaplan E. The Assessment of Aphasia and Related Disorders. 2nd ed. Philadelphia, PA: Lea & Febiger; 1983.